Discussions focus on integrating ECG diagnostics into AI-enabled E-ICU Command Centre and expanding technology-driven healthcare access across underserved regions
MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
New facility will open by October 2026 and house 500 process development specialists
Both nations deepen cooperation in health innovation, AI-driven healthcare, biomedical research, data sharing, and life sciences to accelerate next-generation healthcare solutions
Dr Reddy’s has partnered with MSN Laboratories Private Limited on the product, with Dr Reddy’s holding exclusive US marketing rights while MSN leads development and manufacturing
Samelisant will be the centerpiece of Suven’s scientific presence
The decision was driven by results from the Phase III CAPItello-281 trial,
The regulatory decision follows promising results from RIVER-81
Approval is based on results from the phase 3 OASIS 4 clinical trial
Subscribe To Our Newsletter & Stay Updated
